Judith Ng-Cashin, MD has been appointed chief scientific officer, INC Research. Dr. Ng-Cashin will lead the integration of the company’s therapeutic and medical/scientific expertise for Phase I to IV trials. She will be responsible for scientific, medical and ethical governance, including collaboration with key medical and scientific stakeholders.   Dr. Ng-Cashin has 20 years of drug discovery and development, clinical research, and bench science experience. She joins the company from another ...